543 related articles for article (PubMed ID: 18287136)
1. Neurodegenerative central nervous system disease as late sequelae of Langerhans cell histiocytosis. Report from the Japan LCH Study Group.
Imashuku S; Shioda Y; Kobayashi R; Hosoi G; Fujino H; Seto S; Wakita H; Oka A; Okazaki N; Fujita N; Minato T; Koike K; Tsunematsu Y; Morimoto A;
Haematologica; 2008 Apr; 93(4):615-8. PubMed ID: 18287136
[TBL] [Abstract][Full Text] [Related]
2. Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis.
Grois N; Prayer D; Prosch H; Minkov M; Pötschger U; Gadner H
Pediatr Blood Cancer; 2004 Jul; 43(1):59-65. PubMed ID: 15170891
[TBL] [Abstract][Full Text] [Related]
3. Pattern and course of neurodegeneration in Langerhans cell histiocytosis.
Wnorowski M; Prosch H; Prayer D; Janssen G; Gadner H; Grois N
J Pediatr; 2008 Jul; 153(1):127-32. PubMed ID: 18571550
[TBL] [Abstract][Full Text] [Related]
4. Central nervous system-related permanent consequences in patients with Langerhans cell histiocytosis.
Mittheisz E; Seidl R; Prayer D; Waldenmair M; Neophytou B; Pötschger U; Minkov M; Steiner M; Prosch H; Wnorowski M; Gadner H; Grois N
Pediatr Blood Cancer; 2007 Jan; 48(1):50-6. PubMed ID: 16470521
[TBL] [Abstract][Full Text] [Related]
5. Incidence and pattern of radiological central nervous system Langerhans cell histiocytosis in children: a population based study.
Laurencikas E; Gavhed D; Stålemark H; van't Hooft I; Prayer D; Grois N; Henter JI
Pediatr Blood Cancer; 2011 Feb; 56(2):250-7. PubMed ID: 21157893
[TBL] [Abstract][Full Text] [Related]
6. Failure to treat obstructive hydrocephalus with endoscopic third ventriculostomy in a patient with neurodegenerative Langerhans cell histiocytosis.
Kershenovich A; Price AV; Koral K; Goldman S; Swift DM
J Neurosurg Pediatr; 2008 Nov; 2(5):304-9. PubMed ID: 18976098
[TBL] [Abstract][Full Text] [Related]
7. Reactivation and risk of sequelae in Langerhans cell histiocytosis.
Pollono D; Rey G; Latella A; Rosso D; Chantada G; Braier J
Pediatr Blood Cancer; 2007 Jun; 48(7):696-9. PubMed ID: 17252574
[TBL] [Abstract][Full Text] [Related]
8. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study.
Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S;
Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933
[TBL] [Abstract][Full Text] [Related]
9. Pulmonary abnormalities at long-term follow-up of patients with Langerhans cell histiocytosis.
Bernstrand C; Cederlund K; Sandstedt B; Ahström L; Lundell M; Dahlquist G; Henter JI
Med Pediatr Oncol; 2001 Apr; 36(4):459-68. PubMed ID: 11260569
[TBL] [Abstract][Full Text] [Related]
10. Pineal gland abnormalities in Langerhans cell histiocytosis.
Grois N; Prosch H; Waldhauser F; Minkov M; Strasser G; Steiner M; Unger E; Prayer D
Pediatr Blood Cancer; 2004 Sep; 43(3):261-6. PubMed ID: 15266411
[TBL] [Abstract][Full Text] [Related]
11. [Langerhans cell histiocytosis in the central nervous system: meningeal involvement].
Sánchez Alegre ML; Muñoz Almazán L; Luna Alcalá A; Abadal Villayandre JM; Duque López G
Rev Clin Esp; 1999 Aug; 199(8):520-2. PubMed ID: 10522433
[TBL] [Abstract][Full Text] [Related]
12. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine.
Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ
Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311
[TBL] [Abstract][Full Text] [Related]
13. Cognitive outcome of long-term survivors of multisystem langerhans cell histiocytosis: a single-institution, cross-sectional study.
Nanduri VR; Lillywhite L; Chapman C; Parry L; Pritchard J; Vargha-Khadem F
J Clin Oncol; 2003 Aug; 21(15):2961-7. PubMed ID: 12885816
[TBL] [Abstract][Full Text] [Related]
14. Report of the Histiocyte Society workshop on "Central nervous system (CNS) disease in Langerhans cell histiocytosis (LCH)".
Med Pediatr Oncol; 1997 Aug; 29(2):73-8. PubMed ID: 9180906
[No Abstract] [Full Text] [Related]
15. Neuropsychological sequelae in patients with neurodegenerative Langerhans cell histiocytosis.
Van't Hooft I; Gavhed D; Laurencikas E; Henter JI
Pediatr Blood Cancer; 2008 Nov; 51(5):669-74. PubMed ID: 18623210
[TBL] [Abstract][Full Text] [Related]
16. [Hypothalamic-infundibular histiocytosis: magnetic resonance findings].
Crespo-Rodríguez AM; Franco C; Lidón MC; Izquierdo B; Angulo E; Mazas-Artasona LV
Rev Neurol; 2004 Jul 16-31; 39(2):125-9. PubMed ID: 15264161
[TBL] [Abstract][Full Text] [Related]
17. Neuropathology of CNS disease in Langerhans cell histiocytosis.
Grois N; Prayer D; Prosch H; Lassmann H;
Brain; 2005 Apr; 128(Pt 4):829-38. PubMed ID: 15705614
[TBL] [Abstract][Full Text] [Related]
18. Radiological evaluation of patients with pituitary langerhans cell histiocytosis at diagnosis and at follow-up.
Varan A; Cila A; Akyüz C; Kale G; Kutluk T; Büyükpamukçu M
Pediatr Hematol Oncol; 2008 Sep; 25(6):567-74. PubMed ID: 18728976
[TBL] [Abstract][Full Text] [Related]
19. Skeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivors.
Lau LM; Stuurman K; Weitzman S
Pediatr Blood Cancer; 2008 Mar; 50(3):607-12. PubMed ID: 17973322
[TBL] [Abstract][Full Text] [Related]
20. Follow-up of pediatric patients treated by IVIG for Langerhans cell histiocytosis (LCH)-related neurodegenerative CNS disease.
Imashuku S; Fujita N; Shioda Y; Noma H; Seto S; Minato T; Sakashita K; Ito N; Kobayashi R; Morimoto A;
Int J Hematol; 2015 Feb; 101(2):191-7. PubMed ID: 25491495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
